4.5 Review

Genome-wide association studies of obesity and metabolic syndrome

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 382, Issue 1, Pages 740-757

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2012.08.018

Keywords

Body mass index; Genetics; Genome-wide association studies; Metabolic syndrome; Obesity

Funding

  1. Swedish Foundation for Strategic Research [ICA08-0047]
  2. Swedish Research Council [2009-2298]
  3. Swedish Heart-Lung Foundation [2010-0401]
  4. European Community's Seventh Framework Programme, ENGAGE Consortium [HEALTH-F4-2007-201413]

Ask authors/readers for more resources

Until just a few years ago, the genetic determinants of obesity and metabolic syndrome were largely unknown, with the exception of a few forms of monogenic extreme obesity. Since genome-wide association studies (GWAS) became available, large advances have been made. The first single nucleotide polymorphism robustly associated with increased body mass index (BMI) was in 2007 mapped to a gene with for the time unknown function. This gene, now known as fat mass and obesity associated (FTO) has been repeatedly replicated in several ethnicities and is affecting obesity by regulating appetite. Since the first report from a GWAS of obesity, an increasing number of markers have been shown to be associated with BMI, other measures of obesity or fat distribution and metabolic syndrome. This systematic review of obesity GWAS will summarize genome-wide significant findings for obesity and metabolic syndrome and briefly give a few suggestions of what is to be expected in the next few years. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available